MedTrace Logo

Comparison of Different Physiotherapy Techniques in Dysmenorrhea

NCT07022106 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2025-08-01

No results posted yet for this study

Summary

This study is investigating the effects of myofascial release technique \& kinesiotape in managing dysmenorrhea

Conditions

  • Dysmenorrhea Primary

Interventions

OTHER

Myofascial Release Therapy (MRT) Group

Myofascial Release Therapy (MRT) involves hands-on palpation to detect fascial restrictions, followed by 60-90 seconds of sustained pressure to release tension. In the supine position, the target areas include the superficial fascia, transversalis fascia, and extraperitoneal fascia, while in the prone position, the focus shifts to the thoracolumbar fascia and the erector spinae complex. This technique aims to restore mobility and reduce restrictions within the fascial system. Frequency: Each patient will recieve a single session at their most painful day from this intervention.

OTHER

Kinesiotape (KT) Group

Kinesio Taping (KT) Intervention Description: Participants will receive a standardized 3-tape sensory modulation technique using Kinesiotape, applied to the abdomen and sacrum to target fascial tension and visceral pain in primary dysmenorrhea. Procedure: Abdominal Application (Two Tapes, 0% Stretch): Horizontal Tape: Placed between the iliac crests (lower abdomen) to reduce fascial tension. Vertical Tape: Applied from the navel to the pubic symphysis to modulate visceral pain signaling. Sacral Application (One Tape, 15-25% Stretch): Horizontal Tape: Anchored across the S2-S4 vertebrae (at PSIS level) to activate the pain-gating mechanism via cutaneous-visceral reflexes. Frequency/Duration: Each participant will receive a single session at their most painful day from this intervention

Sponsors & Collaborators

  • Medipol University

    lead OTHER

Principal Investigators

  • Gizem Ergezen Şahin, PhD · Medipol University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-15
Primary Completion
2025-09-30
Completion
2025-10-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07022106 on ClinicalTrials.gov